| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |